Şerafettin Yazar

Şerafettin Yazar

Auto-generated profile, based on publicly available information

Şerafettin Yazar

Memorial Bahçelievler Hospital Transplantation Unit

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SASerdar Aslan
Serdar Aslan
ZYZeliha Akış Yıldız
Zeliha Akış Yıldız
ŞYŞerafettin Yazar
Şerafettin Yazar
AKAhmet Kargı
Ahmet Kargı
RDRamazan Dönmez
Ramazan Dönmez
KPKamil Yalçın Polat
Kamil Yalçın Polat

1 June 2020 in Journal of the Turkish Academy of Dermatology
Verified
Journal Article
Closed access
SENCAN ACARSENCAN ACAR
SENCAN ACAR
ŞYŞerafettin Yazar
Şerafettin Yazar
AKAhmet Kargı
Ahmet Kargı
RDRamazan Dönmez
Ramazan Dönmez
SASerdar Aslan
Serdar Aslan
MAMurat Akyıldız
Murat Akyıldız

30 April 2020 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
RDRamazan Dönmez
Ramazan Dönmez
AKAhmet Kargi
Ahmet Kargi
ŞYŞerafettin Yazar
Şerafettin Yazar
SASerdar Aslan
Serdar Aslan
KPKemal Peker
Kemal Peker
KPKamil Yalçın Polat
Kamil Yalçın Polat
Transplantation procedure used if the recipient and donor do not have a special anatomical variation today; left lateral segment in the pediatric age group, and right lobe in the adult age group. Biliary atresia in children and various liver diseases like metabolic events in adults are the major causes of liver transplantation. Liver transplantation is challenging in the patients with congenital vascular anomalies. Infrahepatic interruption of the inferior vena cava (IVC) is a rare congenital anomaly with the incidence of 0.6% to 2% and mostly found with congenital heart disease. In this study we tried to report a 58-year old male patient with a diagnosis of decompensated liver cirrhosis caused by the hepatitis B virus (HBV) who was hospitalized for the first time for living donor liver transplantation

22 June 2023 in Konuralp Tip Dergisi
Verified
Journal Article
Closed access
SASerdar Aslan
Serdar Aslan
ŞYŞerafettin Yazar
Şerafettin Yazar
AKAhmet Kargi
Ahmet Kargi
EKEray Kurnaz
Eray Kurnaz
DŞDilek Şahi̇n
Dilek Şahi̇n
KPKamil Polat
Kamil Polat
Objective: Hepatocellular cancer (HCC) is the most common malignancy of the hepatobiliary system. There are significant differences in the global spread of HCC. It is the major cause of death in patients with cirrhosis. Its molecular pathogenesis is highly complex and heterogeneous. Major risk factors for the development of HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection and alcohol-related liver cirrhosis. Hepatocellular cancer is rarely seen in the first 4 decades of life, except in communities where HBV infection is hyperendemic. Method: The study was conducted by retrospectively scanning the files of 204 patients diagnosed with HCC who applied to Organ Transplantation Center between 21.09.2014 and 13.04.2019. Patients were transplanted liver by being classified according to Milan criteria, San Francisco [University of California San Francisco (UCSF)] criteria, and Barcelona Clinic Liver Cancer (BCLC) criteria. Result: The median age of the patients was 58.03 (range 31 to 72). 170 of the patients were men and 34 of them were female. Liver transplantation was performed from cadaveric donors to 31 patients and from living donors to 173 patients. There is a significant relationship between the life span of the patients and their gender. Female patients have a longer life expectancy [t (202) = 2,963, p =, 003]. A significant relationship was found between life expectancy and surgical classification [F (3) = 3,008, (p =, 031)]. Conclusion: In patients diagnosed with HCC and undergoing liver transplantation; the gender being female and the classification method before transplantation affect life expectancy.